Literature DB >> 24229615

Electrographic seizures and status epilepticus in critically ill children and neonates with encephalopathy.

Nicholas S Abend1, Courtney J Wusthoff, Ethan M Goldberg, Dennis J Dlugos.   

Abstract

Electrographic seizures are seizures that are evident on EEG monitoring. They are common in critically ill children and neonates with acute encephalopathy. Most electrographic seizures have no associated clinical changes, and continuous EEG monitoring is necessary for identification. The effect of electrographic seizures on outcome is the focus of active investigation. Studies have shown that a high burden of electrographic seizures is associated with worsened clinical outcome after adjustment for cause and severity of brain injury, suggesting that a high burden of such seizures might independently contribute to secondary brain injury. Further research is needed to determine whether identification and management of electrographic seizures reduces secondary brain injury and improves outcome in critically ill children and neonates.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24229615     DOI: 10.1016/S1474-4422(13)70246-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  30 in total

1.  Finding the Lesser of Two Evils: Treating Refractory Status Epilepticus.

Authors:  Lawrence J Hirsch
Journal:  Epilepsy Curr       Date:  2015 Nov-Dec       Impact factor: 7.500

2.  Electrographic status epilepticus and neurobehavioral outcomes in critically ill children.

Authors:  Nicholas S Abend; Katherine L Wagenman; Taylor P Blake; Maria T Schultheis; Jerilynn Radcliffe; Robert A Berg; Alexis A Topjian; Dennis J Dlugos
Journal:  Epilepsy Behav       Date:  2015-04-20       Impact factor: 2.937

3.  Weak supervision as an efficient approach for automated seizure detection in electroencephalography.

Authors:  Khaled Saab; Jared Dunnmon; Daniel Rubin; Christopher Lee-Messer; Christopher Ré
Journal:  NPJ Digit Med       Date:  2020-04-20

4.  Consensus statement on continuous EEG in critically ill adults and children, part I: indications.

Authors:  Susan T Herman; Nicholas S Abend; Thomas P Bleck; Kevin E Chapman; Frank W Drislane; Ronald G Emerson; Elizabeth E Gerard; Cecil D Hahn; Aatif M Husain; Peter W Kaplan; Suzette M LaRoche; Marc R Nuwer; Mark Quigg; James J Riviello; Sarah E Schmitt; Liberty A Simmons; Tammy N Tsuchida; Lawrence J Hirsch
Journal:  J Clin Neurophysiol       Date:  2015-04       Impact factor: 2.177

5.  How much does it cost to identify a critically ill child experiencing electrographic seizures?

Authors:  Nicholas S Abend; Alexis A Topjian; Sankey Williams
Journal:  J Clin Neurophysiol       Date:  2015-06       Impact factor: 2.177

6.  Time to electroencephalography is independently associated with outcome in critically ill neonates and children.

Authors:  Iván Sánchez Fernández; Arnold J Sansevere; Rejean M Guerriero; Ersida Buraniqi; Phillip L Pearl; Robert C Tasker; Tobias Loddenkemper
Journal:  Epilepsia       Date:  2017-01-28       Impact factor: 5.864

Review 7.  Electrographic status epilepticus in children with critical illness: Epidemiology and outcome.

Authors:  Nicholas S Abend
Journal:  Epilepsy Behav       Date:  2015-05-02       Impact factor: 2.937

8.  Quick and accurate quantification of the premature brain.

Authors:  Catherine J Chu
Journal:  Clin Neurophysiol       Date:  2016-05-04       Impact factor: 3.708

9.  The probability of seizures during continuous EEG monitoring in high-risk neonates.

Authors:  Lila T Worden; Dhinakaran M Chinappen; Sally M Stoyell; Jacquelyn Gold; Luis Paixao; Kalpathy Krishnamoorthy; Mark A Kramer; Michael B Westover; Catherine J Chu
Journal:  Epilepsia       Date:  2019-11-19       Impact factor: 5.864

10.  Continuous electroencephalography in pediatric traumatic brain injury: Seizure characteristics and outcomes.

Authors:  Jarin Vaewpanich; Karin Reuter-Rice
Journal:  Epilepsy Behav       Date:  2016-08-05       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.